Ad
related to: gsk
Search results
Is GSK stock a sell with 75,000 Zantac cases moving forward? | Invezz
Invezz· 1 day agoGSK plc (NYSE:GSK) faced a significant setback on June 3rd when its stock plunged by 8% following a...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 17 hours agoUK-based pharmaceutical company GSK has reported updated results from a Phase II study of Jemperli...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
Investing.com· 2 days agoShares in British drugmaker GSK fell sharply Monday following a Delaware judge's decision to allow...
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move...
Benzinga· 1 day agoOn Monday, GSK Plc GSK shares were down after the Delaware State Court ruled that more than 70,000...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg· 2 days agoGSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside others...
GSK Stock Dives After Judge Allows Zantac Cancer Lawsuits To Go Forward
Investopedia· 1 day agoAmerican depositary receipts (ADRs) of GSK Plc (GSK) tumbled in intraday trading Monday after a...
GSK: Still reasons to be cheerful rather than fearful after 'nightmare' Monday
Proactive Investors· 15 hours agoWhat was supposed to be a stellar day for GSK PLC (LSE:GSK, NYSE:GSK) at the annual American Society...
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated...
Benzinga· 1 day agoThe data were presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. On...
GSK shares tumble 9% after 70,000 Zantac lawsuits allowed to move forward
Reuters via AOL· 2 days agoFollowing the ruling, analysts at J.P. Morgan said the potential liability that GSK could face from...
Glaxo (GSK) Up 1.6% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 4 days agoIt has been about a month since the last earnings report for GSK (GSK). Shares have added about 1.6%...